Documenting Dual-Column Experiment with Mini-SHINE Solution
Argonne National Laboratory (Argonne) is assisting SHINE Medical Technologies (SHINE) in developing a production method and recovery and purification processes for molybdenum 99 (Mo-99) using an accelerator-driven, subcritical target consisting of an aqueous uranyl-sulfate solution. An integral part of the process is the development of a column for the separation and recovery of Mo-99, followed by a concentration column to reduce the product volume from 15–25 L to <1 L prior to entry into the low-enriched uranium (LEU)-Modified Cintichem purification process. Argonne has developed plant-scale column designs for the initial Mo-recovery column and the concentration column.
Stepinski, Dominique C.↗